Biblio

Export 1238 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
Journal Article
L. Ordoñez-Gutierrez, Fernandez-Perez, I., Herrera, J. Luis, Anton, M., Benito-Cuesta, I., and Wandosell, F., “AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging.”, J Alzheimers Dis, vol. 54, no. 2, pp. 645-56, 2016.
S. Sindi, Ngandu, T., Hovatta, I., Kåreholt, I., Antikainen, R., Hänninen, T., Levälahti, E., Laatikainen, T., Lindström, J., Paajanen, T., Peltonen, M., Khalsa, D. Singh, Wolozin, B., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Solomon, A., “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
N. Cortés, Andrade, V., and Maccioni, R. B., “Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.”, J Alzheimers Dis, 2018.
A. Douglass, Walterfang, M., Velakoulis, D., and Abel, L., “Behavioral Variant Frontotemporal Dementia Performance on a Range of Saccadic Tasks.”, J Alzheimers Dis, vol. 65, no. 1, pp. 231-242, 2018.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
I. Chalatsa, Arvanitis, D. A., Mikropoulou, E. V., Giagini, A., Papadopoulou-Daifoti, Z., Aligiannis, N., Halabalaki, M., Tsarbopoulos, A., Skaltsounis, L. A., and Sanoudou, D., “Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.”, J Alzheimers Dis, vol. 64, no. 3, pp. 787-800, 2018.
I. Chalatsa, Arvanitis, D. A., Mikropoulou, E. V., Giagini, A., Papadopoulou-Daifoti, Z., Aligiannis, N., Halabalaki, M., Tsarbopoulos, A., Skaltsounis, L. A., and Sanoudou, D., “Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.”, J Alzheimers Dis, vol. 64, no. 3, pp. 787-800, 2018.
M. J. Andersson and Stone, J., “Best Medicine for Dementia: The Life-Long Defense of the Brain.”, J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
P. - F. Meyer, Savard, M., Poirier, J., Labonte, A., Rosa-Neto, P., Weitz, T. M., Town, T., and Breitner, J., “Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.”, J Alzheimers Dis, vol. 63, no. 2, pp. 577-590, 2018.
K. Ohno, Abdelhamid, M., Zhou, C., Jung, C. - G., and Michikawa, M., “Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1413-1425, 2022.
S. R. Alves, Silva, Cda Cruz E., Martins, I., Henriques, A. Gabriela, and Silva, O. A. B. da Cru, “A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1917-1933, 2022.
J. Peter, Schumacher, L. V., Landerer, V., Abdulkadir, A., Kaller, C. P., Lahr, J., and Klöppel, S., “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
B. Borroni, Benussi, A., Premi, E., Alberici, A., Marcello, E., Gardoni, F., Di Luca, M., and Padovani, A., “Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1113-1123, 2018.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
C. Robb, Udeh-Momoh, C., Wagenpfeil, S., Schöpe, J., Alexopoulos, P., and Perneczky, R., “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
C. Robb, Udeh-Momoh, C., Wagenpfeil, S., Schöpe, J., Alexopoulos, P., and Perneczky, R., “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
A. Mishima, Nihashi, T., Ando, Y., Kawai, H., Kato, T., Ito, K., and Terasawa, T., “Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 161-74, 2016.
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres, “Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
C. Pappas, Small, B. J., Andel, R., Laczó, J., Pařízková, M., Ondrej, L., and Hort, J., “Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.”, J Alzheimers Dis, 2018.
D. A. Levine, Gross, A. L., Briceño, E. M., Tilton, N., Whitney, R., Han, D., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Elkind, M. S. V., Moran, A. E., Tom, S., Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., Sacco, R. L., Heckbert, S. R., Hughes, T. M., Lopez, O. L., Allen, N. Bai, and Galecki, A. T., “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M., “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
S. Westwood, Leoni, E., Hye, A., Lynham, S., Khondoker, M. R., Ashton, N. J., Kiddle, S. J., Baird, A. L., Sainz-Fuertes, R., Leung, R., Graf, J., Hehir, C. Tan, Baker, D., Cereda, C., Bazenet, C., Ward, M., Thambisetty, M., and Lovestone, S., “Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.”, J Alzheimers Dis, vol. 52, no. 2, pp. 561-72, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., “Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
S. Kawanishi, Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., and Ashihara, E., “Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 563-585, 2018.
E. Fiorenzato, Biundo, R., Cecchin, D., Frigo, A. Chiara, Kim, J., Weis, L., Strafella, A. P., and Antonini, A., “Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.”, J Alzheimers Dis, vol. 66, no. 1, pp. 229-237, 2018.

Pages